Combining blood-based biomarkers to predict risk for Alzheimer’s disease dementia

被引：0
作者：
Suzanne E. Schindler
Randall J. Bateman
机构：
[1] Washington University School of Medicine,Department of Neurology
[2] Washington University School of Medicine,Knight Alzheimer’s Disease Research Center
[3] Washington University School of Medicine,Hope Center for Neurological Disorders
来源：
Nature Aging | 2021年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Accurate blood tests for Alzheimer’s disease (AD) are critical tools that have the potential to revolutionize dementia research, clinical trials and clinical care. Models combining blood-based biomarkers that represent multiple aspects of AD brain pathology with key individual level factors may improve prediction of AD dementia.
引用
收藏
页码：26 / 28
页数：2
相关论文
共 23 条
[11]  
Karikari TK(2014)undefined N. Engl. J. Med. 370 377-390
[12]  
Preische O(2008)undefined Neurotherapeutics 5 381-1294
[13]  
Mattsson N(2014)undefined Sci. Transl. Med. 6 228fs213-undefined
[14]  
Cullen NC(2019)undefined JAMA 321 1286-undefined
[15]  
Andreasson U(undefined)undefined undefined undefined undefined-undefined
[16]  
Zetterberg H(undefined)undefined undefined undefined undefined-undefined
[17]  
Blennow K(undefined)undefined undefined undefined undefined-undefined
[18]  
Karran E(undefined)undefined undefined undefined undefined-undefined
[19]  
Hardy J(undefined)undefined undefined undefined undefined-undefined
[20]  
Bateman RJ(undefined)undefined undefined undefined undefined-undefined
123